Non-invasive prenatal diagnosis for Down syndrome: The paradigm will shift, but slowly

Ultrasound in Obstetrics and Gynecology

Volumn 39, Issue 2, 2012, Pages 127-130

  Benn, P ^a   Cuckle, H ^b   Pergament, E ^c  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c Northwestern Reproductive Genetics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DOWN SYNDROME; FEMALE; FIRST TRIMESTER PREGNANCY; GENETIC COUNSELING; GENETICS; HUMAN; KARYOTYPING; MASS SCREENING; METHODOLOGY; PREGNANCY; PRENATAL DIAGNOSIS; RISK ASSESSMENT;

DOWN SYNDROME; FEMALE; GENETIC COUNSELING; HUMANS; KARYOTYPING; MASS SCREENING; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PRENATAL DIAGNOSIS; RISK ASSESSMENT;

EID: 84856328923     PISSN: 09607692     EISSN: 14690705     Source Type: Journal    
DOI: 10.1002/uog.11083     Document Type: Note

References (25)

1. Chiu RW, Akolekar R, Zheng YW, Leung TY, Sun H, Chan KC, Lun FM, Go AT, Lau ET, To WW, Leung WC, Tang RY, Au-Yeung SK, Lam H, Kung YY, Zhang X, van Vugt JM, Minekawa R, Tang MH, Wang J, Oudejans CB, Lau TK, Nicolaides KH, Lo YM,. Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validation study. BMJ 2011; 342: c7401.
2. Sehnert AJ, Rhees B, Comstock D, de Feo E, Heilek G, Burke J, Rava RP,. Optimal detection of fetal chromosome abnormalities by massively parallel sequencing of cell-free fetal DNA from maternal blood. Clin Chem 2011; 57: 1042-1049.
3. Ehrich M, Deciu C, Zweifellhofer T, Tynan JA, Cagasan L, Tim R, Lu V, McCullough R, McCarthy E, Nygren AO, Dean J, Tang L, Hutchison D, Lu T, Wang H, Angkachatchai V, Oeth P, Cantor CR, Bombard A, van den Boom D,. Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting. Am J Obstet Gynecol 2011; 204: 205.e201-211.
4. Palomaki GE, Kloza EM, Lambert-Messerlian GM, Haddow JE, Neveux LM, Ehrich M, van den Boom D, Bombard AT, Deciu C, Grody WW, Nelson SF, Canick JA,. DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study. Genet Med 2011; 13: 913-920.
5. Benn P, Borrell A, Crossley J, Cuckle H, Dugoff L, Gross S, Johnson JA, Maymon R, Odibo A, Schielen P, Spencer K, Wright D, Yaron Y,; International Society for Prenatal Diagnosis. Aneuploidy screening: a position statement from a committee on behalf of the Board of the International Society for Prenatal Diagnosis, January 2011. Prenat Diagn 2011; 31: 519-522.
6. Rhoads GG, Jackson LG, Schlesselman SE, de la Cruz FF, Desnick RJ, Golbus MS, Ledbetter DH, Lubs HA, Mahoney MJ, Pergament E, Simpson JL, Carpenter RJ, Elias S, Ginsberg NA, Goldberg JD, Hobbins JC, Lynch L, Shiono PH, Wapner RJ, Zachary JM,. The safety and efficacy of chorionic villus sampling for early prenatal diagnosis of cytogenetic abnormalities. N Engl J Med 1989; 320: 609-617. (Pubitemid 19072465)
7. Grati FR, Barlocco A, Grimi B, Milani S, Frascoli G, Di Meco AM, Liuti R, Trotta A, Chinetti S, Dulcetti F, Ruggeri AM, De Toffol S, Clementi M, Maggi F, Simoni G,. Chromosome abnormalities investigated by non-invasive prenatal testing account for approximately 50% of fetal unbalances associated with relevant clinical phenotypes. Am J Med Genet A 2010; 152A: 1434-1442.
8. Chen EZ, Chiu RW, Sun H, Akolekar R, Chan KC, Leung TY, Jiang P, Zheng YW, Lun FM, Chan LY, Jin Y, Go AT, Lau ET, To WW, Leung WC, Tang RY, Au-Yeung SK, Lam H, Kung YY, Zhang X, van Vugt JM, Minekawa R, Tang MH, Wang J, Oudejans CB, Lau TK, Nicolaides KH, Lo YM,. Noninvasive prenatal diagnosis of fetal trisomy 18 and trisomy 13 by maternal plasma DNA sequencing. PLoS One 2011; 6: e21791.
9. Benn PA, Chapman AR,. Ethical challenges in providing noninvasive prenatal diagnosis. Curr Opin Obstet Gynecol 2010; 22: 128-134.
10. Benn PA, Borrell A, Cuckle H, Dugoff L, Gross S, Johnson J, Maymon R, Odibo A, Schielen P, Spencer K, Wright D, Yaron Y,. Prenatal detection of Down syndrome using massively parallel sequencing (MPS): a rapid response position statement from a committee on behalf of the Board of the International Society for Prenatal Diagnosis, 24 October 2011; [Accessed 30 October 2011].
11. Hahn S, Huppertz B, Holzgreve W,. Fetal cells and cell free fetal nucleic acids in maternal blood: new tools to study abnormal placentation? Placenta 2005; 26: 515-526. (Pubitemid 40916304)
12. Alberry MS, Maddocks DG, Hadi MA, Metawi H, Hunt LP, Abdel-Fattah SA, Avent ND, Soothill PW,. Quantification of cell free fetal DNA in maternal plasma in normal pregnancies and in pregnancies with placental dysfunction. Am J Obstet Gynecol 2009; 200: 98.e1-6.
13. th edn, Milunsky A, Milunsky JM, (eds). Johns Hopkins University Press: Baltimore, 2010; 771-818.
14. Kagan KO, Staboulidou I, Cruz J, Wright D, Nicolaides KH,. Two-stage first-trimester screening for trisomy 21 by ultrasound assessment and biochemical testing. Ultrasound Obstet Gynecol 2010; 36: 542-547.
15. Akolekar R, Syngelaki A, Sarquis R, Zvanca M, Nicolaides KH,. Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11-13 weeks. Prenat Diagn 2011; 31: 66-74. Erratum in: Prenat Diagn 2011; 31: 832.
16. Bujold E, Roberge S, Lacasse Y, Bureau M, Audibert F, Marcoux S, Forest JC, Giguère Y,. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol 2010; 116: 402-414.
17. Nicolaides KH,. A model for a new pyramid of prenatal care based on the 11 to 13 weeks' assessment. Prenat Diagn 2011; 31: 3-6.
18. Secretary's Advisory Committee on Genetics, Health, and Society (SACGHS), 2008; US system for oversight of genetic testing: a response to the charge of the Secretary of Health and Human Services. [Accessed 30 October 2011].
19. Bianchi D,. At-home fetal DNA gender testing: caveat emptor. Obstet Gynecol 2006; 107: 216-218.
20. Go AT, van Vugt JM, Oudejans CB,. Non-invasive aneuploidy detection using free fetal DNA and RNA in maternal plasma: recent progress and future possibilities. Hum Reprod Update 2011; 17: 372-382.
21. Papageorgiou EA, Karagrigoriou A, Tsaliki E, Velissariou V, Carter NP, Patsalis PC,. Fetal-specific DNA methylation ratio permits noninvasive prenatal diagnosis of trisomy 21. Nat Med 2011; 17: 510-513.
22. Lo YM, Chan KC, Sun H, Chen EZ, Jiang P, Lun FM, Zheng YW, Leung TY, Lau TK, Cantor CR, Chiu RW,. Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus. Sci Transl Med 2010; 2: 61ra91.
23. Calabrese G, Baldi M, Fantasia D, Teresa Sessa M, Kalantar M, Holzhauer C, Alunni-Fabbroni M, Palka G, Sitar G,. Detection of chromosomal aneuploidies in fetal cells isolated from maternal blood using single-chromosome dual-probe FISH analysis. Clin Genet 2011; [Epub ahead of print].
24. Cooper GM, Shendure J,. Needles in stacks of needles: finding disease-causal variants in a wealth of genomic data. Nat Rev Genet 2011; 12: 628-640.
25. Bell CJ, Dinwiddie DL, Miller NA, Hateley SL, Ganusova EE, Mudge J, Langley RJ, Zhang L, Lee CC, Schilkey FD, Sheth V, Woodward JE, Peckham HE, Schroth GP, Kim RW, Kingsmore SF,. Carrier testing for severe childhood recessive diseases by next-generation sequencing. Sci Transl Med 2011; 3: 65ra4.